Cover Feature: Exploring the Chemical Space of Mycobacterial Oxidative Phosphorylation Inhibitors Using Molecular Modeling (ChemMedChem 22/2024)

The Cover Feature focuses on the role of molecular modeling in designing new therapeutic agents (inhibitors) for tuberculosis, Hansen's disease, and nontuberculous mycobacterial (NTM) pulmonary disease by facilitating the targeting of the mycobacterial oxidative phosphorylation (OXPHOS) pathway and ATP synthase. The designed inhibitors are specific in disrupting bacterial energy production by exploiting structural differences between the mycobacterial and human isoforms of the OXPHOS enzymes as revealed by molecular modeling. More information can be found in article 10.1002/cmdc.202400303 by Chérif F. Matta and co-workers.